Fabrys sygdom
Artikel

When to treat
Think Fabry, think early treatment to help slow or prevent life-threatening disease progression.1,2

Fabry disease
Fabry disease is an X-linked lysosomal storage disease due to a defect in the gene encoding the lysosomal enzyme alpha-galactosidase A (α-Gal A), causing progressive cellular accumulation of the substrate globotriaosylceramide (GL-3) and globo-triaosylsphingosine (lyso-GL-3).

Cardiac involvement in Fabry disease
Cardiovascular disease is the leading cause of death in Fabry disease patients.1 Undiagnosed and untreated Fabry disease leads to progressive, irreversible, life-threatening heart injury.2,3

Renal involvement in Fabry disease
Think Fabry, think renal involvement that may present early in life and could go undetected.
Leave site modal
Du er ved at forlade campus.sanofi/dk. Sanofi er ikke ansvarlig for indholdet af dette eksterne websted.
Arbejder du inden for sundhedsvæsenet?
Arbejder du inden for sundhedsvæsenet?
Denne hjemmeside indeholder kun information, der er rettet mod sundhedspersoner. Bekræft venligst nedenfor for at modtage information, film, podcasts og andet materiale.